Testosterone is being hailed as the secret to better energy, mood, and sex drive. Here’s what experts say about when it ...

Professor Anthony Rodgers from The George Institute said that this new pill could help millions of people and reduce the burden on healthcare systems. The study shows that using this kind of ...

Industry representatives are asking Ottawa for more support, including protection from low-cost products made in China and ...

Explore the outstanding achievements of the National Academy of Medicine (NAM) Class of 2025, including groundbreaking ...

Roche’s test, which measures the blood level of pTau181, a protein that builds up in the brain tissue of Alzheimer’s patients ...

West Virginia could be the 2nd state in the U.S. to require insurance companies to cover cooling caps to minimize hair loss ...

Oura announced today that it's pursuing FDA clearance for a feature that will notify users if the ring detects signs of high blood pressure.

The FDA has approved Genentech’s Gazyva (obinutuzumab) for the treatment of lupus nephritis in adults, according to a news release published today. Gazyva is the first and only anti-CD20 monoclonal ...

Oura’s latest update resdesigns the iOS and Android app to better display your health information. Plus, it's starting ...

Oura is launching a redesigned app that offers expanded stress-tracking insights and is developing new features to detect signs of hypertension.

The anti-CD20 antibody, developed by Roche’s Genentech along with Biogen and already approved for multiple oncology indications, is branching into autoimmune disease. Its B cell–targeting mechanism of ...

The company has received approval to validate and define the feature in a study that is scheduled to start this year.